Immediate Impact
34 standout
Citing Papers
Glioblastoma: Clinical Presentation, Multidisciplinary Management, and Long-Term Outcomes
2025 Standout
Artificial intelligence in drug development
2025 Standout
Works of Tim Heffernan being referenced
Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1
2023
EGFR Amplification Induces Increased DNA Damage Response and Renders Selective Sensitivity to Talazoparib (PARP Inhibitor) in Glioblastoma
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Tim Heffernan | 98 | 54 | 19 | 44 | 6 | 188 | |
| Robert F. Koncar | 68 | 31 | 34 | 22 | 6 | 141 | |
| Gabrielle Ernst | 177 | 60 | 7 | 16 | 5 | 280 | |
| Eric Vroegindeweij | 105 | 17 | 20 | 17 | 9 | 282 | |
| Andrés López‐Hernandez | 74 | 70 | 25 | 59 | 5 | 219 | |
| Luke A. Wylie | 140 | 25 | 14 | 35 | 5 | 255 | |
| Antonis Kokkalis | 114 | 17 | 9 | 15 | 6 | 159 | |
| Janson W.T. Tse | 196 | 20 | 7 | 31 | 8 | 255 | |
| Naomi Akagi | 94 | 30 | 7 | 23 | 7 | 223 | |
| Chelsea L. Dieck | 67 | 13 | 23 | 46 | 9 | 162 | |
| Ailith Ewing | 41 | 45 | 10 | 39 | 7 | 152 |
All Works
Loading papers...